Amphastar Pharmaceuticals (AMPH) Minority Interest (2018 - 2021)
Historic Minority Interest for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Q2 2021 value amounting to $45.2 million.
- Amphastar Pharmaceuticals' Minority Interest rose 105.91% to $45.2 million in Q2 2021 from the same period last year, while for Jun 2021 it was $45.2 million, marking a year-over-year increase of 105.91%. This contributed to the annual value of $46.4 million for FY2020, which is 55.24% up from last year.
- According to the latest figures from Q2 2021, Amphastar Pharmaceuticals' Minority Interest is $45.2 million, which was up 105.91% from $45.4 million recorded in Q1 2021.
- Over the past 5 years, Amphastar Pharmaceuticals' Minority Interest peaked at $46.4 million during Q4 2020, and registered a low of $21.9 million during Q3 2018.
- Its 4-year average for Minority Interest is $42.3 million, with a median of $45.3 million in 2019.
- Its Minority Interest has fluctuated over the past 5 years, first surged by 10247.09% in 2019, then plummeted by 99.65% in 2021.
- Over the past 4 years, Amphastar Pharmaceuticals' Minority Interest (Quarter) stood at $31.9 million in 2018, then surged by 44.6% to $46.2 million in 2019, then rose by 0.55% to $46.4 million in 2020, then decreased by 2.56% to $45.2 million in 2021.
- Its Minority Interest was $45.2 million in Q2 2021, compared to $45.4 million in Q1 2021 and $46.4 million in Q4 2020.